Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
Age-related changes in spleen of Dark Agouti rats immunized for experimental autoimmune encephalomyelitis.
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.
16 Syndrome in a Patient With Multiple Sclerosis.
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.
[Quality of life in multiple sclerosis--association with clinical features, fatigue and depressive syndrome].
Therapeutic effects of nonerythropoietic erythropoietin analog ARA290 in experimental autoimmune encephalomyelitis rat.
Ocular and cervical vestibular evoked myogenic potentials in patients with multiple sclerosis.
Multiple sclerosis guideline production takes off.
Impact of anger on the health-related quality of life of multiple sclerosis patients.
Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
Demographic and clinical factors associated with changes in employment in multiple sclerosis.
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.
Acute mountain sickness in athletes with neurological impairments.
Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
Functional ionotropic glutamate receptors on peripheral axons and myelin.
Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs.
Epidemiology and clinical record of multiple sclerosis in selected countries - a systematic review.
Baló's concentric sclerosis: imaging findings and pathological correlation.
Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.
Evolution of diagnostic criteria for multiple sclerosis.
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation.
Multiple sclerosis: Natalizumab to fingolimod-the washout whitewash.
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study.
Pages
« first
‹ previous
…
450
451
452
453
454
455
456
457
458
…
next ›
last »